HRCT is used for diagnosis and assessment of
interstitial lung disease, such as
pulmonary fibrosis, and other generalized lung diseases such as
emphysema and
bronchiectasis.
Lung disease Airways diseases, such as
emphysema or
bronchiolitis obliterans, cause
air trapping on expiration, even though they may cause only minor changes to lung structure in their early stages. To enhance sensitivity for these conditions, the scan may be performed in both inspiration and expiration. HRCT may be diagnostic for conditions such as emphysema or bronchiectasis. While HRCT may be able to identify pulmonary fibrosis, it may not always be able to further categorize the fibrosis to a specific pathological type (e.g.,
non-specific interstitial pneumonitis or
desquamative interstitial pneumonitis). The major exception is UIP, which has very characteristic features, and may be confidently diagnosed on HRCT alone. Where HRCT is unable to reach a definitive diagnosis, it helps locate an abnormality, and so helps planning a
biopsy, which may provide the final diagnosis. Other miscellaneous conditions where HRCT is useful include
lymphangitis carcinomatosa, fungal, or other atypical, infections, chronic pulmonary vascular disease,
lymphangioleiomyomatosis, and
sarcoidosis. Organ transplant patients, particularly lung, or heart-lung transplant recipients, are at relatively high risk of developing pulmonary complications of the long-term drug and
immunosuppressive treatment. The major pulmonary complication is
bronchiolitis obliterans, which may be a sign of lung graft rejection. HRCT has better sensitivity for bronchiolitis obliterans than conventional radiography. Some transplant centers may arrange annual HRCT to screen for this. Diagnostic imaging, including HRCT, is one of the main diagnostic tools for
COVID-19. There is some debate about the usefulness of CT compared to other methods and imaging modalities for diagnosis. Under HRCT scan, infected individuals generally showed a multifocal or unifocal involvement of
ground-glass opacity (GGO).
Nodularity The presence of
lung nodules on high resolution CT is a keystone in understanding the appropriate differential. Typically, the distribution of nodules is divided into perilymphatic, centrilobular and random categories. Furthermore, nodules can be ill-defined, implying they are in the
alveoli, or well defined, suggesting an
interstitial position. Distribution and appearance allow understanding of the disease process relative to the secondary lobule of the lung, the smallest anatomic unit with surrounding connective tissue, usually 1–2 cm across. Perilymphatic nodularity deposits at the periphery of the secondary lobule and tends to respect pleural surfaces and fissures.
Sarcoidosis,
lymphangitic spread of carcinoma,
silicosis,
coal worker's pneumoconiosis, and more rare diagnoses such as
lymphoid interstitial pneumonitis and
amyloidosis are included in the differential. Centrilobular nodularity deposits at the center of the secondary lobule, but spares pleural surfaces. Differential includes endobronchial
tuberculosis,
bronchopneumonia,
endobronchial spread of tumor, and again silicosis or coal workers' pneumoconiosis. For randomly distributed nodules, the differential includes miliary tuberculosis,
fungal pneumonia, hematogenous
metastasis and diffuse sarcoidosis. == See also ==